KIVEXA Vs TRUVADA, Both Administered With Efavirenz, In ART-Naive Subjects

PHASE4CompletedINTERVENTIONAL
Enrollment

392

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Infection, Human Immunodeficiency Virus IHIV Infection
Interventions
DRUG

Abacavir/lamivudine and efavirenz

DRUG

Tenofovir/Emtricitabine and efavirenz

Trial Locations (68)

7

GSK Investigational Site, Dublin

8

GSK Investigational Site, Dublin

1000

GSK Investigational Site, Brussels

1011

GSK Investigational Site, Lausanne

3000

GSK Investigational Site, Leuven

3010

GSK Investigational Site, Bern

4031

GSK Investigational Site, Basel

5000

GSK Investigational Site, Odense C

6000

GSK Investigational Site, Charleroi

8000

GSK Investigational Site, Bruges

8038

GSK Investigational Site, Zurich

8091

GSK Investigational Site, Zurich

8200

GSK Investigational Site, Aarhus N

9000

GSK Investigational Site, Ghent

9007

GSK Investigational Site, Sankt Gallen

10149

GSK Investigational Site, Turin

13353

GSK Investigational Site, Berlin

20025

GSK Investigational Site, Legnano (MI

20127

GSK Investigational Site, Milan

20142

GSK Investigational Site, Milan

20146

GSK Investigational Site, Hamburg

20246

GSK Investigational Site, Hamburg

28034

GSK Investigational Site, Madrid

30159

GSK Investigational Site, Hanover

30625

GSK Investigational Site, Hanover

40237

GSK Investigational Site, Düsseldorf

41100

GSK Investigational Site, Modena

44100

GSK Investigational Site, Ferrara

45122

GSK Investigational Site, Essen

46015

GSK Investigational Site, Valencia

47900

GSK Investigational Site, Rimini

69115

GSK Investigational Site, Heidelberg

80335

GSK Investigational Site, Munich

92300

GSK Investigational Site, Levallois-Perret

92380

GSK Investigational Site, Garches

93205

GSK Investigational Site, Saint-Denis

A-6020

GSK Investigational Site, Innsbruck

A-5020

GSK Investigational Site, Salzburg

A-1090

GSK Investigational Site, Vienna

A-1140

GSK Investigational Site, Vienna

DK-9000

GSK Investigational Site, Aalborg

DK-2100

GSK Investigational Site, Copenhagen

DK-2650

GSK Investigational Site, Hvidovre

04170

GSK Investigational Site, Leipzig

00149

GSK Investigational Site, Rome

LV 1006

GSK Investigational Site, Riga

1815 JD

GSK Investigational Site, Alkmaar

9713 GZ

GSK Investigational Site, Groningen

3078 HT

GSK Investigational Site, Rotterdam

2512 VA

GSK Investigational Site, The Hague

3584 CX

GSK Investigational Site, Utrecht

2720-276

GSK Investigational Site, Amadora

M8 5RB

GSK Investigational Site, Manchester

SE18 4QH

GSK Investigational Site, Woolwich, London

EH4 2XU

GSK Investigational Site, Edinburgh

BN2 1ES

GSK Investigational Site, Brighton

B4 6DH

GSK Investigational Site, Birmingham

WS2 9PS

GSK Investigational Site, Birmingham

BL4 0JR

GSK Investigational Site, Farnworth, Bolton

GL1 3NN

GSK Investigational Site, Gloucester

LE1 5WW

GSK Investigational Site, Leicester

E1 1BB

GSK Investigational Site, London

N18 1QX

GSK Investigational Site, London

NW3 2QG

GSK Investigational Site, London

SW10 9TH

GSK Investigational Site, London

SW17 0QT

GSK Investigational Site, London

TS4 3BW

GSK Investigational Site, Middlesbrough

S10 2JF

GSK Investigational Site, Sheffield

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY